<?xml version="1.0" encoding="UTF-8"?>
<p>Exploratory efficacy endpoints will include the mean change from baseline to study end in Modified Fatigue Severity Scale (FSS), number of patients with improvement of ≥4 points in Medical Research Council (MRC) sum score at week 12 or at time of rescue medication, and Short‐Form 36‐item (SF‐36) health survey physical component score, mental component score, and their 8 health domains; and the time to decrease in MRC sum score to baseline (or below) after temporary increase.</p>
